Dr. Eric B Haura's Credentials

Accepting New Patients

Yes, this doctor is accepting new patients

Biography

Dr. Eric Haura received his undergraduate degree in Biomedical Engineering from the Johns Hopkins University in 1990 and completed medical school at Duke University School of Medicine in 1994. He returned to Johns Hopkins and completed a residency program in internal medicine in 1997. He then went on to Duke to pursue a clinical fellowship in hematology and oncology and a research fellowship in genetics. He completed both programs in 2000. He joined the H. Lee Moffitt Cancer Center and Research Institute in the Department of Thoracic Oncology in 2000 and is currently a Senior Member. He is the Director of the Moffitt Lung Cancer Center of Excellence.  He led the CCSG Molecular Medicine Program for 10 years.  He is currently the Associate Center Director for Clinical Science.  Dr. Haura's major contribution has been as a leader in advancing the field of translational cancer proteomics and molecular characterization of cancers using highly integrative mass spectrometry-based proteomics. He has characterized protein architectures that regulate tumor growth and response to therapy. He developed approaches to discern mechanisms of complex drugs in cancer allowing repurposing of drugs and expanded uses. He has published more than 200 papers in top-tier scientific journals including Science Signaling, Nature Chemical Biology, Proceedings of the National Academy of Sciences, Molecular Systems Biology, Journal of Clinical Oncology, and Cancer Research. He has received numerous grants through the National Cancer Institute, industry partners, and private foundations. He has served as a consultant for numerous pharmaceutical companies as well as lung cancer research centers. He is a member of the American Association of Cancer Research, the International Association for the Study of Lung Cancer, and the American Society of Clinical Oncology, and the Human Proteome Organization. He has served as a grant reviewer for the National Cancer Institute, American Cancer Society, and private lung cancer research foundations. He received the ASCO Advanced Clinical Research Award in 2007. He was named Moffitt Research Scientist of the Year in 2011 and was named Research Mentor of the Year in 2009. In 2014 he was inducted into the American Society of Clinical Investigation, one of the nation's oldest and most respected honor societies for physician-scientists. Dr. Haura is an expert in the management of lung cancer. He has designed and executed numerous clinical trials exploring new agents for the treatment of lung cancer. He is interested in biomarkers to predict therapeutic responses in lung cancer and is active in developing molecular based therapeutic clinical trials. He has organized the department's genome medicine strategy to bring precision medicine to the bedside and is interested in migrating new platforms to the bedside to assist in clinical decision making.

Education

• Duke University School of Medicine (Grad. 2000)

Areas of Expertise

• Lung Cancer